Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Ronald Li’s post on LinkedIn, adding:
“Very interesting and informative in vitro studies.
You may want to investigate this further with Resia Pretorius and the PolyBio team who are looking for better treatment of microclotting, post infection Illnesses, including Long COVID PASC.
Perhaps desulfated-heparin analogs could help better mitigate the development of severe life-threatening NETosis dysregulation and circulatory decline, if tried in vivo.
However, I still prefer trying NETs/extracellular chromatin/histone removal from the blood using these emerging extracorporeal blood purification treatments for patients at high-risk of refractory SIRS and development of life-threatening sepsis/DIC.
Based on the largely failed clinical performance of systemically administered Activated Protein C, I have long believed the depletion of circulating charged histones and other extracellular chromatin debris that aggregates cells, rather than drug neutralization of histones, provides the greatest opportunity for restoring immune system homeostasis and improving blood hemostasis in response to infection and other triggers of worsening NETosis dysregulation.”
Ronald Li, Associate Professor in Emergency and Critical Care at North Carolina State University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Veterinary Science:
“Congratulations Dr. Maria Andrea Guzman Solano on this publication.
As a member of the graduating class of the Veterinary Academic Leadership Fellow program at NC State College of Veterinary Medicine, she successfully advanced her research idea from conception through execution to publication.
I am excited to see her continue this research path as she takes on a new role as Associate Professor of Emergency and Critical Care at the University of Missouri.”
Title: Non-anticoagulant heparin attenuates histone-mediated platelet–leukocyte aggregation and neutrophil extracellular trap formation in a canine whole blood model
Authors: Maria A. Guzmán, Lunden Simpson, Ronald H. L. Li
Other posts featuring Jim Hoffman on Hemostasis Today.
-
Oct 24, 2026, 16:57Pall T. Onundarson: Fiix Prothrombin Time Advancing Precision in Anticoagulation Management
-
Oct 24, 2026, 16:42Mark-Anthony Johnson: Blood Type Awareness and Emergency Transfusion
-
Oct 24, 2026, 16:27Pedro Perez: Florida’s Push to Strengthen VTE Prevention
-
Oct 24, 2026, 16:23Kathleen Freson: Human Cell Models Advance Research into Rare Platelet Disorders
-
Oct 24, 2026, 16:18Victor Daniel: Deep Learning for Automated Platelet Classification
-
Oct 24, 2026, 16:08Paula Alonso-Frías: Human Umbilical Cord Blood Platelet-Rich Plasma for Endometrial Regeneration
-
Oct 24, 2026, 16:00Fatma Ebeid: Ain Shams University Hosts TIF Experts for Collaborating Center Evaluation
-
Oct 24, 2026, 15:52Mazen A. Juratli: Platelet-Derived Extracellular Vesicles as Potential Predictors of Survival in Liver Cancer
-
Oct 24, 2026, 14:28Satyam Arora: Umbilical Cord Blood for Neonatal Transfusions